Projects View

Johnson & Johnson to Invest $2 billion in Advanced Biologics manufacturing Plant in North Carolina, USA

Johnson & Johnson to Invest $2 billion in Advanced Biologics manufacturing Plant in North Carolina, USA

Specifications:

Name:

Johnson & Johnson to Invest $2 billion in Advanced Biologics manufacturing Plant in North Carolina, USA

Location:

North Carolina, USA

Company:

Johnson & Johnson

Estimated Cost:

$2 billion

Source:

https://www.jnj.com/

Introduction

Johnson & Johnson has announced plans to invest over $2 billion to develop a cutting-edge biologics manufacturing plant in Wilson, North Carolina.

Features

The plant will bolster production capacity for the company’s portfolio and pipeline of groundbreaking biologics, aligning with Johnson & Johnson's broader aim to advance over 70 new therapy filings and product launches by the end of the decade.

This facility will focus on manufacturing innovative biologic medicines in key areas such as oncology, immunology, and neuroscience. Equipped with advanced technology, it will ensure efficient and high-quality production processes. Once fully operational, it is expected to provide approximately 420 full-time roles for highly skilled professionals.

Construction is scheduled to commence in the first half of 2025.